Abcodia, AIT Collaborate to Validate Cancer Biomarkers | GenomeWeb

NEW YORK (GenomeWeb News) – UK cancer biomarker firm Abcodia today announced a collaboration with the Austrian Institute of Technology to validate biomarkers for the early detection of lung and colorectal cancers.

Accessing a longitudinal collection of serum samples derived from a population cohort involved in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), Abcodia and AIT will design longitudinal studies to validate panels of biomarkers.

UKCTOCS is a randomized controlled trial for assessing the effect of screening on mortality.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.